TVTX News & Analysis

Travere Therapeutics (TVTX) Form 144 Filed on April 1, 2023

Travere Therapeutics (TVTX) filed Form 144 on April 1, 2023, reporting potential sales of its shares. This form typically indicates the intention of insiders to sell stock, which could affect investor sentiment and trading activity. The exact number of shares or details regarding the potential sales were not disclosed in the article. Monitoring such filings is vital for assessing insider activities and market context.